Phase III Randomized Trial for Use of Docetaxel in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation. Vanita Noronha, MBBS MD DM Amol Patel Nandini Menon Ezra Cohen Journal of Clinical Oncology P.D.Hinduja Hospital Khar Tata Memorial Hospital Robert Haddad ascopubs.org/doi/abs/10.120…

the study gives an important message that if something works in pallaitive setting. It is not necessary that it will work in curative setting.

Long term outcomes of phase I/II study of palliative triple metronomic... sciencedirect.com/science/articl… Sachin Dhumal Vanita Noronha, MBBS MD DM Nandini Menon Pan Pantziarka Cancer Research and Statistics Foundation (CRSF) Head and Neck Cancer International Group

"Understanding cancer a little better" - read our latest blog here: bit.ly/41QGnib Reviewed by Dr. (Prof). Vijay Patil ( Consultant - Medical Oncology) at P.D. Hinduja Hospital, Khar Unit. #OncoCare #medicaloncology #cancersupport #cancertreatmentinindia #HindujaKhar

Thursday National Molecular Tumor Board & Precision Oncology "discussion on difficult case with #TP53 and #CTNNB1 gene" #pathwayanalysis #tumorboard #PrecisionMedicine kothari rushabh P.D.Hinduja Hospital Khar Dr (Prof). Vijay Patil

⁦ZEE २४ तास⁩ ⁦Head & Neck Connect⁩ ⁦Cancer Awareness⁩ ⁦Bharat⁩ ⁦Vanita Noronha, MBBS MD DM⁩ ⁦Nandini Menon⁩ ⁦Dr (Prof). Vijay Patil⁩

Intensive protocol development at ACTREC. Thank you so much mentors for the great inputs. Dr (Prof). Vijay Patil Santam Chakraborty Vikram gota Supriya Chopra Indranil Mallick AstraZeneca India AstraZeneca Dr.Mangesh Kamle @behal_shruti #AASPIRE23 #Medicaloncology #residentlife #tmh

pubmed.ncbi.nlm.nih.gov/36980719/. adjuvant RT in single node positive patient fails the test of randomise trial. No benefit in OS. Deteriorates QOL. Has some impact on locoregional failure. Time to change guidelines Dr Amol Akhade Sujith kothari rushabh Nandini Menon Vanita Noronha, MBBS MD DM

The results are more relevant in India. Where oral cavity has a high incidence. Radiation resources are scare. The QOL of life deterioration would be much higher as most conventional RT- cobalt. Santam Chakraborty Head and Neck Cancer International Group Prathamesh Pai Prof. Anil D'Cruz Amol Patel Sachin Dhumal

ejcancer.com/article/S0959-…

CAR T therapy for lay person . youtu.be/o1X9kmiuNjg?si…. ZEE २४ तास Rahul Purwar Bharat Vanita Noronha, MBBS MD DM kothari rushabh Ravi Prakash Santam Chakraborty ashayoncology Dr.Harsha Doddihal P. D. Hinduja Hospital P.D.Hinduja Hospital Khar G Khanna

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma | NEJM nejm.org/doi/full/10.10…

Repotrectinib showing promising activity in phase 2 . Awaiting the start of phase 3 in India. ⁦Vanita Noronha, MBBS MD DM⁩ ⁦Nirmal Raut⁩ ⁦Bharat⁩ nejm.org/doi/full/10.10…

Sotorasib plus Panitumumab. Not great results but seems some prolongation in outcomes ⁦NEJM⁩ ⁦Anant Ramaswamy⁩ ⁦Prabhat Bhargava, DM (Medical Oncology)⁩ ⁦Nandini Menon⁩ nejm.org/doi/full/10.10…

Tarla tamal a new option in SCLC ⁦Nandini Menon⁩ ⁦Suresh S. Ramalingam, MD, FASCO⁩ ⁦Ramila⁩ ⁦Prabhat Malik⁩ nejm.org/doi/full/10.10…

First commercial CAR T journey in Mumbai started. Thank to ashayoncology Devanshi Kalra P.D.Hinduja Hospital Khar won’t have been possible without blessings from Dr Navin K , Dr Kumar Vanita Noronha, MBBS MD DM . Great innovation Rahul Purwar Gaurav Narula MD .

Long term results of our regimen in EGFR mutation positive NSCLC. The combination is active ⁦Vanita Noronha, MBBS MD DM⁩ ⁦Nandini Menon⁩ ⁦Dr Amol Akhade⁩ ⁦Lung Connect India⁩ ⁦Sewanti Limaye 🇮🇳🇺🇸⁩ ⁦Navneet Singh⁩ ⁦Prabhat Malik⁩ jamanetwork.com/journals/jamao…